Evidence map›Paper›PMID 38168435›Full record

ArticlebioRxiv : the preprint server for biology2024

Inhibition of

Jianwen Chen, Bao Zhao, Hong Dong, Tianliang Li, Xiang Cheng, Wang Gong, Jing Wang, Junran Zhang, Gang Xin, Yanbao Yu and 4 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Jianwen ChenDepartment of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
Bao ZhaoDepartment of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
Hong DongDepartment of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
Tianliang LiDepartment of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
Xiang ChengDepartment of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
Wang GongDepartment of Periodontics and Oral Medicine, University of Michigan School of Dentistry, University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48105, USA.
Jing WangPelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Junran ZhangPelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Gang XinDepartment of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
Yanbao YuDepartment of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA.
Yu L LeiDepartment of Periodontics and Oral Medicine, University of Michigan School of Dentistry, University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48105, USA.
Jennifer D BlackEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Zihai LiPelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Haitao WenDepartment of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, OH 43210, USA.
The Ohio State University · USUniversity of Michigan · USUniversity of Delaware · USUniversity of Nebraska Medical Center · US

Funding

Restoring the Immunogenicity of Head and Neck CancerR01DE026728 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Yu Leo Lei, James J. Moon · 2018 to 2026
$4.3M
Molecular chaperones and immune toleranceR01AI077283 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2009 to 2021
$3.7M
Targeting immune inhibitory molecule SUSD2 to reverse immunosuppressionR01AI162779 · NIAID · OHIO STATE UNIVERSITY · PI WEN, HAITAO · 2021 to 2025
$2.3M
Targeting GPR84 to Overcome Macrophage Mediated Resistance to ImmunotherapyR01CA269984 · NCI · OHIO STATE UNIVERSITY · PI Gang Xin · 2023 to 2026
$1.4M
Mitochondrial metabolism in microbial sepsisR01GM135234 · NIGMS · OHIO STATE UNIVERSITY · PI WEN, HAITAO · 2019 to 2022
$1.2M
NCI NIH HHS R01 CA269984NIAID NIH HHS R01 AI077283NIAID NIH HHS R01 AI162779NIDCR NIH HHS R01 DE026728NIGMS NIH HHS R01 GM135234
6 · The paper itself

Abstract

The

Identifiers

PMID38168435
PMCPMC10760207
OpenAlexW4389781891

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.